PET–CT for radiotherapy treatment planning and response monitoring in solid tumors

@article{Bussink2011PETCTFR,
  title={PET–CT for radiotherapy treatment planning and response monitoring in solid tumors},
  author={Johan Bussink and Johannes H. A. M. Kaanders and Winette T. A. van der Graaf and Wim J. G. Oyen},
  journal={Nature Reviews Clinical Oncology},
  year={2011},
  volume={8},
  pages={233-242}
}
PET imaging has evolved as an indispensible tool for staging in oncology. Multiple quantitative measurements can be performed, enabling the effects of treatment to be monitored before changes are detectable with the use of conventional imaging modalities. PET tracers are available to visualize and quantify the most important mechanisms of resistance to radiotherapy and chemoradiotherapy. Reproducibility of these tracers depends on the particular tracer and the underlying biology of the process… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Explore Further: Topics Discussed in This Paper

Citations

Publications citing this paper.
Showing 1-10 of 32 extracted citations

Preclinical Assessment of Efficacy of Radiation Dose Painting Based on Intratumoral FDG-PET Uptake.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2015

References

Publications referenced by this paper.
Showing 1-10 of 102 references

A systematic methodology review of phase I radiation dose escalation trials.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology • 2010

A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer

Muijs, T C.
Radiother. Oncol • 2010

Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer (14)C-EF3 in animal tumor models.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology • 2010

Similar Papers

Loading similar papers…